![ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE](/abs-image/US/2017/06/01/US20170151344A1/abs.jpg.150x150.jpg)
基本信息:
- 专利标题: ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
- 申请号:US15363786 申请日:2016-11-29
- 公开(公告)号:US20170151344A1 公开(公告)日:2017-06-01
- 发明人: Kurt C. GISH , Jonathan A. Hickson , Susan Elizabeth Morgan-Lappe , James W. Purcell
- 申请人: AbbVie Inc. , AbbVie Biotherapeutics Inc.
- 主分类号: A61K47/48
- IPC分类号: A61K47/48 ; A61K38/07 ; A61K31/5517 ; C07K16/30
摘要:
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
公开/授权文献:
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K47/00 | 以所用的非有效成分为特征的医用配制品,如载体、惰性添加剂 |
--------A61K47/48 | .非有效成分被化学键键合到有效成分上,例如聚合物药物轭合物 |